Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation

International Journal of Molecular Sciences(2025)10.3390/ijms26031347Source: DataRank Database

Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.39)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Vincent Wagner ORCID,Andrew Polio,Katharine Linder,David Bender ORCID,Michael J. Goodheart ORCID

Live enrichment

PubMed:39941116 PMC:PMC11818617 OpenAlex:https://openalex.org/W4407174059

NIH

Grant: 5R01CA99908-18

NIH

Grant: OC190352

American Association of Obstetricians and Gynecologists Foundation (AAOGF) Bridge Funding Award

Grant: AAOGF 2018

NCI NIH HHS

Grant: R01 CA099908

University of Iowa Department of Obstetrics and Gynecology

Grant: 2016

NHLBI NIH HHS

Grant: T32 HL007344

National Institutes of Health

Grant: 7R01CA099908-19

Targeted Therapy for Endometrial Cancer

FWCI

1.39

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/26/3/1347/pdf

GOLDhttps://doi.org/10.3390/ijms26031347

publisherhttps://www.mdpi.com/1422-0067/26/3/1347/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39941116

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11818617

Fields of Study

Cancer-related molecular mechanisms researchRNA modifications and cancerCancer Genomics and DiagnosticsMedicineBiology03 medical and health sciences0302 clinical medicine

MeSH Terms

Exome SequencingAgedDNA, MitochondrialFemaleHumansMiddle AgedOvarian NeoplasmsRetrospective StudiesGenetic VariationCystadenocarcinoma, SerousGenes, MitochondrialNeoplasm Grading

Keywords

Ovarian cancerSerous carcinomaBiologySerous fluidOvarian carcinomaMitochondrial DNACancerStage (stratigraphy)DiseaseGeneExomeOncologyInternal medicineBioinformaticsExome sequencingMedicineGeneticsMutationGenetic variationPrediction modelRna Sequencing—rnaseqWhole-exome Sequencing—wesOvarian NeoplasmsMiddle AgedDNA, MitochondrialArticleCystadenocarcinoma, SerousGenes, MitochondrialHumansFemaleNeoplasm GradingAgedRetrospective Studies

Sustainable Development Goals

SDG 0: Reduced inequalities

Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation

FAIR Checklist

Authors (7)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)